open access
Background
Previous
studies have indicated that intake of dietary
flavonoids or flavonoid
subclasses is associated with the ovarian cancer risk, but presented
controversial results. Therefore, we conducted a meta-analysis to derive
a more precise estimation of these associations.
The characteristics of the included studies were presented in Table 1,
of which nine were high-quality studies (scores≥7.0). The selected
studies were published between 2003 and 2014 spanning 11 years, and all
of them were published in English. Among these 12 studies, 5 were
prospective cohort studies, 7 were case-control studies, including 5
population based case-control studies, and 2 hospital based case-control
studies. Moreover, 6 studies were from USA, 2 from China, and the rest
were respectively from United Kingdom, Swedish, Australian, and Italy.
The exposure assessments of flavonoids and flavonoid subclasses in 12
studies were made by questionnaire or published food composition data
bases.
Moreover, results from Egger’s tests indicated no evidence of publication bias among these studies (p = 0.26). (Fig 6).
Conclusions
In
summary, the available evidence suggested that intake of dietary
flavonoids, flavonoid subclasses (isoflavones, flavonols) has a
protective effect against ovarian cancer with a reduced incidence of
ovarian cancer. While the evidence for possible protection of flavones
consumption against ovarian cancer was not compelling. The findings
likely provide useful insight and evidence which can be used by
healthcare professionals when discussing dietary flavonoids and ovarian
cancer prevention with patients. While, further investigations on a
larger population covering more other different flavonoid subclasses are
required to confirm our findings.
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.